Summary
For FY2026/3 (full year), the company delivered revenue of JPY 4,129M (+38.3% YoY), achieving top-line growth. However, operating income fell to JPY -399M as multiple headwinds converged: disposal of unprofitable inventory discovered post-Kanarabo acquisition, goodwill impairment related to RiLi, and restructuring charges associated with the divestiture of the lifestyle business. Management characterized FY2026/3 as "a year to flush out all the problems," committing to an operating income turnaround (guidance: JPY 50M) and adjusted EBITDA recovery to JPY 324M in FY2027/3. During the earnings call, management candidly acknowledged shortcomings in due diligence during the Kanarabo acquisition, while pointing to tangible signs of a growth inflection—citing strong momentum for Fujiko's new product "Keana Odamari! Cream" and MiiS's high-ASP electric toothbrush "LIFT BRUSH" exceeding JPY 10M on its first day on Makuake.
Key Points (Earnings Takeaways and Growth Initiatives)
- Business Strategy and Market Positioning
- Emphasized that in niche markets, cross-channel coverage (proprietary EC + third-party EC + retail + directly-operated stores) creates a defensive moat by capturing market share across all touchpoints
- Expanding M&A scope beyond branded companies to include unbranded manufacturers and service businesses, aiming to unlock value through brand-building
- Repeatedly highlighted the leverage inherent in parent company management costs not scaling proportionally with revenue, and referenced AI-driven efficiencies to further optimize administrative costs
- Current Business Progress and Key Drivers
- Post-acquisition of Kanarabo, the company discovered unprofitable inventory exceeding initial expectations; b idol return rate improved from 24.5% in Q3 to 9.2% in Q4, though management openly acknowledged the due diligence shortfall
- Matsumura Shoten's deterioration in COGS ratio was primarily driven by a time lag in passing through yen depreciation to selling prices; systems are now in place, with normalization expected from the current fiscal year
- MiiS Q4 revenue of JPY 179M reflected temporary transaction restrictions related to clinic operations during the medical corporation consolidation process
- Strategic Initiatives and Key Inflection Points
- MiiS launched its first high-ASP product "LIFT BRUSH" via advance sales on Makuake, exceeding JPY 10M on day one; aimed at improving proprietary EC advertising CPA and lifting AOV
- Fujiko's "Keana Odamari! Cream" achieved ~3x initial sales projections during pre-launch, with nationwide rollout commencing across ~3,600 stores
- Acquired distribution rights for "WHOMEE," the cosmetics brand by Shinobu Igari; launch planned after rebranding is completed in the next fiscal year
- Divested the lifestyle segment's SNS marketing support business to Lovable Marketing Group for JPY 700M, concentrating management resources on proprietary brand operations
Outlook and Strategy
- FY2027/3 full-year guidance calls for revenue of JPY 6,602M (+59.9% YoY) and operating income of JPY 50M, targeting a return to profitability. The full-year consolidation of Kanarabo is the primary driver
- VISION2029 targets for FY2029/3: revenue of JPY 15B, operating income of JPY 1.5B, and market capitalization of JPY 30B
- Plans for 2+ M&A transactions in FY2027/3, but shifting to a conservative approach of incorporating deals into guidance only after confirming PMI progress
- Overseas expansion strategy centers on leveraging Fujiko's Greater China distribution channels (13.0% of H2 revenue) as a shared group platform, with Middle East entry via the UCI investment to be pursued once geopolitical conditions stabilize
- Organic growth assumptions are conservatively set at 10% annually, with M&A-driven upside targeted to deliver both top-line expansion and OPM improvement
- Existing brand support operations (Matsumura Shoten contract manufacturing + Rice Curry Plus) to be managed as cash cows, maintaining ~JPY 1.4B in annual revenue while improving margins
Positive Factors
- Fujiko proprietary EC revenue +48.6% pre/post-PMI and Matsumura Shoten EC revenue +538.6%, building a compelling track record of PMI repeatability
- MiiS "LIFT BRUSH" surpassed JPY 10M on its Makuake launch day, positioned as a catalyst for proprietary EC revenue expansion via high-ASP products
- bialne subscription retention rate remains elevated at 94.8%, underpinned by a healthy D2C model with no first-month discounting
- Proprietary brand revenue mix reached 63.4% in H2, demonstrating continued shift toward higher-margin operations
- Adjusted net income of JPY 310M (+95.0% YoY) marked a record high, partly driven by JPY 652M gain on the sale of Rice Curry LS
- Secured ~JPY 300M in funding from UCI (Middle East-focused fund), providing financial backing for Middle East market entry
Concerns and Risks
- Goodwill balance of JPY 2,311M is elevated relative to net assets of JPY 1,086M, with potential for further accumulation as M&A activity accelerates
- Interest-bearing debt expanded to JPY 3,541M (+78.5% YoY), with equity ratio declining to 19.2%
- Management's own admission of insufficient due diligence during the Kanarabo acquisition raises the risk of similar issues in future M&A transactions
- Achieving VISION2029 requires accelerating both the volume (10+ deals over three years) and scale of M&A, leaving meaningful pipeline uncertainty
- Middle East expansion timeline remains unclear due to geopolitical risk; management explicitly stated during the call that full-scale entry would proceed only once the regional situation stabilizes
- Consolidated gross profit margin edged down to 53.6% (vs. 54.3% prior year), with FX fluctuations and raw material cost inflation potentially sustaining this trend
Performance Highlights
FY2026/3 consolidated revenue reached JPY 4,129M (+38.3% YoY), achieving top-line growth. The proprietary brand segment surged to JPY 2,266M (+125.5% YoY), driven by the full-year contribution of Matsumura Shoten and the addition of Kanarabo to the group. However, FX headwinds, cost increases, and impairment charges on unprofitable operations resulted in an operating loss of JPY -399M and net loss attributable to owners of parent company of JPY -368M. Adjusted net income came in at JPY 310M (+95.0% YoY), supported by gains on the sale of affiliate shares.
- Fujiko Proprietary EC Buyers: 6,334; AOV: JPY 3,894 (Nov 2025–Mar 2026)
- Fujiko Wholesale Store Count: 10,356 stores
- MiiS Proprietary EC Buyers: 17,623; AOV: JPY 7,025 (full year)
- MiiS Third-Party EC Buyers: 97,693; AOV: JPY 3,495 (full year)
- bialne Subscription Members: 5,157; Retention Rate: 94.8%
- b idol Return Rate: Improved from 24.5% in Q3 → 9.2% in Q4
- Adjusted EBITDA: JPY -118M (prior year: JPY 235M)
- Adjusted Net Income: JPY 310M (+95.0% YoY)
Envalith, Inc. ("Envalith") provides exclusive research coverage services to domestic and international institutional investors, as well as domestic individual investors, with the objective of contributing to the development of global and Japanese capital markets by providing information necessary for considering investments in Japanese listed companies.
- Purpose and Disclaimer Regarding Investment Decisions
This report has been prepared solely for informational purposes and does not constitute a solicitation to acquire, sell, or hold securities or any other financial products. Furthermore, this report does not constitute specific investment, financial, or tax advice. Any opinions, judgments, or recommendations contained herein are not intended to induce investment activities. Please be advised that all investment decisions must be made based on the investor's own responsibility and judgment, and Envalith and subject company shall not be involved in any such investment decisions.
- Information Sources, Accuracy, and Disclaimer of Warranty
This report has been prepared based on a formal request from the subject company, utilizing information provided by and interviews conducted with said company. By using this report, you are deemed to have agreed to the following: 1. Information Sources: This report is prepared on the assumption that the publicly available information and information disclosed by the subject company and provided during interviews is true and reliable. Envalith has not independently verified or validated the veracity of such information. 2. Accuracy: The interpretations, analyses, and hypotheses or conclusions based thereon contained in this report are independently derived by Envalith using its own perspectives and analytical methods based on the information mentioned in the preceding paragraph. 3. Disclaimer of Warranty: In the event that there are errors or omissions in the information disclosed by the subject company, Envalith and subject company shall not be held liable for any inaccuracies in this report resulting therefrom. Envalith and subject company make no warranties, whether express or implied, regarding the accuracy, safety, validity, completeness, or any other aspect of this report, nor regarding the past or future performance of the subject company.
- Limitation of Liability
Envalith and subject company shall not be liable for any costs, damages, or losses (including direct, indirect, incidental, consequential, or punitive damages) arising from the use of this report or the information obtained therefrom. Users of this report acknowledge and agree that such use is at their own risk.
- Potential Conflicts of Interest
Envalith may have, or may have in the future, business relationships with the subject company. Accordingly, investors should be aware that conflicts of interest may exist that could affect the objectivity of this report.
- No Obligation to Change or Update Content
The contents and opinions in this report, as well as the information upon which it is based, are current as of the date of preparation and are subject to change without notice. Please be advised that Envalith is under no obligation to update the contents of this report, and investors must verify the timeliness of the information on their own.
- Governing Language
This report is prepared in Japanese, English, and Chinese. In the event of any discrepancy or difference in interpretation between the language versions, the Japanese version shall be treated as the original and shall prevail.
- Copyright
All rights (including copyrights) relating to this report belong to Envalith. Any reproduction, redistribution, or other use of all or part of this report without the prior written permission of Envalith is strictly prohibited.
- Use for Other Investment Products
Except where Envalith has provided prior written approval, the use of this report and the trademarks or trade names of Envalith or the subject company in connection with the information distribution, transaction, sales promotion, or advertising of any investment products (including derivatives, structured products, investment trusts, or investment assets whose price, return, or performance is based on or linked to this report) is strictly prohibited.